Business Description
Lakefront Biotherapeutics NV is a Belgian biotechnology company founded in 1999 and based in Mechelen, with operations across the United States and Europe. The company researches and develops treatments for cancer and immune system disorders, with several drugs currently in clinical trials targeting conditions such as lupus, lymphoma, and multiple myeloma. It works in partnership with Gilead Sciences and was previously known as Galapagos NV before changing its name in May 2026.
